129399-79-7

Upstream product

• 670-95-1 4-phenyl-1H-imidazole 
• 68-12-2 N,N-dimethyl-formamide 
• 129399-78-6 N,N-dimethyl-4-phenylimidazole-1-sulfonamide 

Downstream Products

• 1351515-60-0 (E,Z)-2-(2-(5-phenyl-1H-imidazol-2-yl)vinyl)quinoxaline 
• 1351516-99-8 2-(hydroxymethyl)-N,N-dimethyl-4-phenyl-1H-imidazole-1-sulfonamide 
• 1351517-00-4 N,N-dimethyl-4-phenyl-2-((quinoxalin-2-yloxy)methyl)-1H-imidazole-1-sulfonamide 
• 1351515-63-3 (E,Z)-N,N-dimethyl-2-(2-(1-oxo-1,2-dihydroisoquinolin-3-yl)vinyl)-4-phenyl-1H-imidazole-1-sulfonamide 
• 1351515-64-4 (E,Z)-3-(2-(4-phenyl-1H-imidazol-2-yl)vinyl)isoquinolin-1(2H)-one 

Relevant academic research and scientific papers

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes